Mercer Island, WA, United States of America

Thomas R Martin

This inventor holds 1 USPTO granted patent. Top assignee: Zymogenetics, Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas R Martin. Retrieved from https://idiyas.com/inventor/thomas-r-martin-jynww2z5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas R. Martin: Innovator in Neutrophil Chemotaxis

Introduction

Thomas R. Martin is a notable inventor based in Mercer Island, WA (US). He has made significant contributions to the field of biochemistry, particularly in the area of neutrophil chemoattractants. His work focuses on the development of proteins that enhance neutrophil chemotaxis, which is crucial for various medical applications.

Latest Patents

Thomas R. Martin holds a patent for "Neutrophil chemoattractants." This patent describes substantially pure porcine proteins that possess chemoattractant activity for neutrophils. The methods for preparing these proteins are also detailed in the patent. These proteins are valuable in compositions aimed at promoting the formation of granulation tissue. Additionally, they can be utilized in developing both inflammatory and anti-inflammatory agents.

Career Highlights

Throughout his career, Thomas has been associated with Zymogenetics, Inc., where he has contributed to innovative research and development. His expertise in biochemistry and protein engineering has positioned him as a key figure in his field.

Collaborations

Thomas has collaborated with notable colleagues, including Richard B. Goodman and John W. Forstrom. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Thomas R. Martin's work in neutrophil chemoattractants exemplifies the impact of innovative research in biochemistry. His contributions continue to influence the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…